Atlas Trials

Mesenchymal Stem Cells in the Treatment of Refractory Primary Immune Thrombocytopenia

Clinical trial NCT06813157 · WITHDRAWN

Trial details

NCT number
NCT06813157
Sponsor
Guangzhou Bio-gene Technology Co., Ltd
Status
WITHDRAWN
Phase
Not Applicable
Study type
INTERVENTIONAL
ITP - Immune Thrombocytopenia
Start date
2024-11-11
Primary completion
2028-12-31
Enrollment
0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.